EMD SERONO INC FDA Approval NDA 020357

NDA 020357

EMD SERONO INC

FDA Drug Application

Application #020357

Documents

Letter1998-10-22
Letter2000-12-15
Letter2004-03-24
Letter2008-08-28
Review1999-09-22
Letter2001-04-23
Letter2002-01-08
Letter2004-03-24
Letter2006-11-06
Label2000-02-15
Label2006-11-06
Label2008-08-29
Review1997-11-06
Review1998-10-22
Review2000-12-15
Review2007-04-11
Label2017-04-11
Label2017-04-11
Letter2017-04-12
Letter2017-04-12
Letter2018-05-31
Label2018-05-31
Review1994-07-13

Application Sponsors

NDA 020357EMD SERONO INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued005

Application Products

001TABLET;ORAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1GLUCOPHAGEMETFORMIN HYDROCHLORIDE
002TABLET;ORAL850MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1GLUCOPHAGEMETFORMIN HYDROCHLORIDE
003TABLET;ORAL625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1GLUCOPHAGEMETFORMIN HYDROCHLORIDE
004TABLET;ORAL750MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1GLUCOPHAGEMETFORMIN HYDROCHLORIDE
005TABLET;ORAL1GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1GLUCOPHAGEMETFORMIN HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1995-03-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1995-09-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1996-04-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-07-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1997-06-06PRIORITY
LABELING; LabelingSUPPL6AP1997-11-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1998-05-15PRIORITY
LABELING; LabelingSUPPL8AP1998-02-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1998-07-02PRIORITY
EFFICACY; EfficacySUPPL10AP1998-10-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1998-11-05PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1998-11-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1998-12-04PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1999-06-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1999-03-12PRIORITY
EFFICACY; EfficacySUPPL17AP1999-09-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1999-06-07PRIORITY
EFFICACY; EfficacySUPPL19AP2000-12-15STANDARD
EFFICACY; EfficacySUPPL20AP2001-04-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP2000-08-04PRIORITY
LABELING; LabelingSUPPL22AP2001-02-08STANDARD
LABELING; LabelingSUPPL24AP2002-01-08STANDARD
LABELING; LabelingSUPPL26AP2004-03-19STANDARD
LABELING; LabelingSUPPL27AP2004-03-19STANDARD
LABELING; LabelingSUPPL30AP2006-11-01STANDARD
LABELING; LabelingSUPPL31AP2008-08-27STANDARD
LABELING; LabelingSUPPL34AP2018-05-30UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2013-03-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2013-11-13PRIORITY
LABELING; LabelingSUPPL37AP2017-04-05STANDARD
LABELING; LabelingSUPPL39AP2017-04-05901 REQUIRED

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL9Null0
SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL18Null0
SUPPL19Null8
SUPPL21Null0
SUPPL34Null6
SUPPL35Null0
SUPPL36Null0
SUPPL37Null6
SUPPL39Null15

CDER Filings

EMD SERONO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20357
            [companyName] => EMD SERONO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"GLUCOPHAGE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"GLUCOPHAGE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"850MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"GLUCOPHAGE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"GLUCOPHAGE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"750MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"GLUCOPHAGE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"1GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"05\/30\/2018","submission":"SUPPL-34","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020357s034,021202s018lbl.pdf\"}]","notes":""},{"actionDate":"04\/05\/2017","submission":"SUPPL-39","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020357s037s039,021202s021s023lbl.pdf\"}]","notes":""},{"actionDate":"04\/05\/2017","submission":"SUPPL-37","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020357s037s039,021202s021s023lbl.pdf\"}]","notes":""},{"actionDate":"08\/27\/2008","submission":"SUPPL-31","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/020357s031,021202s016lbl.pdf\"}]","notes":""},{"actionDate":"11\/01\/2006","submission":"SUPPL-30","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020357s030,021202s015lbl.pdf\"}]","notes":""},{"actionDate":"12\/15\/2000","submission":"SUPPL-19","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2000\\\/20357S019_Glucophage_prntlbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"GLUCOPHAGE","submission":"METFORMIN HYDROCHLORIDE","actionType":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"GLUCOPHAGE","submission":"METFORMIN HYDROCHLORIDE","actionType":"850MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"GLUCOPHAGE","submission":"METFORMIN HYDROCHLORIDE","actionType":"625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"GLUCOPHAGE","submission":"METFORMIN HYDROCHLORIDE","actionType":"750MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"GLUCOPHAGE","submission":"METFORMIN HYDROCHLORIDE","actionType":"1GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2018-05-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.